Results 111 to 120 of about 65,257 (310)
Rate of Recurrent Guillain-Barré Syndrome After mRNA COVID-19 Vaccine BNT162b2.
JAMA Neurology, 2021 Rate of Recurrent Guillain-Barré Syndrome After mRNA COVID-19 Vaccine BNT162b2 On December 20, 2020, Israel initiated a national vaccination program against COVID-19.
S. Shapiro Ben David +2 more
semanticscholar +1 more source
World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.Abstract Objectives To compare the effectiveness of vacuum‐assisted closure (VAC) against traditional drainage technique, using a retrospective case‐control study design, in terms of managing deep neck infections (DNIs). Methods Patients presenting to Peking Union Medical College Hospital diagnosed with DNIs were recruited in this study.
Mu Wang +3 more
wiley +1 more source
Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria.
Brain : a journal of neurology, 2014 Guillain-Barré syndrome is an acute polyradiculoneuropathy with a variable clinical presentation. Accurate diagnostic criteria are essential for patient care and research, including clinical trials and vaccine safety studies.
C. Fokke +5 more
semanticscholar +1 more source
World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.ABSTRACT Spasmodic dysphonia is a laryngeal dystonia that can present as adductor, abductor, or mixed types, with or without tremor. The etiology is not understood fully. Comprehensive evaluation is required to establish the diagnosis. Treatments include voice therapy, medications, botulinum toxin injection, laryngeal surgery, deep brain stimulation ...
Aaron J. Jaworek, Robert T. Sataloff
wiley +1 more source
Incidence of Guillain-Barre syndrome among patients with Campylobacter infection: A general practice research database study [PDF]
, 2006 The association between Campylobacter infection and subsequent Guillain-Barre syndrome (GBS) has been well documented. To date, however, there exists no direct estimate of the incidence of GBS among patients with Campylobacter infection.
Hayward, A +5 more
core
COVID-19 vaccine and Guillain-Barré syndrome: let’s not leap to associations
Brain : a journal of neurology, 2020 This special commentary refers to ‘Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome’ by Keddie et al. (doi:10.1093/brain/awaa433).
M. Lunn +6 more
semanticscholar +1 more source
Clinical and Experimental Neuroimmunology, EarlyView.Abstract Objectives It is known that the benefit of intravenous methylprednisolone (IVMP) in multiple sclerosis‐related optic neuritis (MS‐ON) is limited to an accelerated recovery. We aimed to evaluate the impact of time from symptoms onset to IVMP initiation and of IVMP dose on visual recovery among people with MS‐ON.
Hadar Gilad +3 more
wiley +1 more source
UNDERSTANDING THE PATIENT’S RECALLED EXPERIENCE OF AN ACUTE EPISODE OF GUILLAIN-BARRE’ SYNDROME: A QUALITATIVE DESCRIPTIVE STUDY [PDF]
, 2015 Guillain-Barre’ syndrome (GBS) is a rare disease that affects the peripheral nervous system. It is autoimmune in nature and generally presents with areflexia and paresthesias that can lead to total paralysis.
Hooks, Jerry Dwayne, Jr.
core
Prognosis of Guillain-Barré Syndrome in Children [PDF]
, 2016 How to Cite This Article: Salehiomran MR, Nikkhah A, Mahdavi M. Prognosis of Guillain-Barré syndrome in Children. Iran J Child Neurol. Spring 2016; 10(2):38-41.AbstractObjectiveGuillain-Barre Syndrome (GBS) is an acute polyradiculoneuropathy ...
MAHDAVI, Mohadese +2 more
core +2 more sources
Organoid Models to Study Human Infectious Diseases
Cell Proliferation, EarlyView.Our manuscript reviews the role of organoids as models for studying human infectious diseases, highlighting their irreplaceable contributions to drug testing and vaccine development for significant infectious diseases including HIV, ZIKV, SARS‐CoV‐2 and MPXV.
Sijing Zhu +4 more
wiley +1 more source